Parallel Advisors, LLC Dynavax Technologies Corp Transaction History
Parallel Advisors, LLC
- $4.31 Billion
- Q1 2025
A detailed history of Parallel Advisors, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Parallel Advisors, LLC holds 2,056 shares of DVAX stock, worth $21,197. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,056
Previous 2,117
2.88%
Holding current value
$21,197
Previous $27,000
3.7%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding DVAX
# of Institutions
289Shares Held
131MCall Options Held
507KPut Options Held
374K-
Black Rock Inc. New York, NY21.9MShares$226 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$183 Million10.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$94.4 Million0.0% of portfolio
-
State Street Corp Boston, MA7.79MShares$80.4 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.56MShares$67.6 Million5.31% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.3B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...